The main thing I took away from my reading was the comment towards the end where it is stated that they are aiming for $50M revenue - be it by growth and/or aquistitions.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
PDI Chris Judd’s Talk Ya Book: Predictive Discovery finally coming to its 'pointy end' - and it's gunning for gold